501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombo...
501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus
About this item
Full title
Author / Creator
Publisher
London: Lupus Foundation of America
Journal title
Language
English
Formats
Publication information
Publisher
London: Lupus Foundation of America
Subjects
More information
Scope and Contents
Contents
BackgroundPlatelet-bound complement activation products (PC4d) are associated with a history of thrombosis in systemic lupus erythematosus (SLE) (Gartshteyn al., 2021; Petri et al., 2017). The current study evaluated the role of PC4d in assessing the risk of future thrombosis.MethodsPC4d (expressed at net mean fluorescence intensity [MFI]) was meas...
Alternative Titles
Full title
501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c053cadfe36a46afb9d2ddb050548950
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c053cadfe36a46afb9d2ddb050548950
Other Identifiers
E-ISSN
2053-8790
DOI
10.1136/lupus-2022-lupus21century.18
